Engineering the delivery system for CRISPR-based genome editing

Glass, Zachary, Lee, Matthew, Li, Yamin, Xu, Qiaobing·2018·Trends in biotechnology

Cited by (347)

Items 101–200 of 347

  1. Plant biomacromolecule delivery methods in the 21st century
    Sachin Rustgi, Salman Naveed, Jonathan Windham, Huan Zhang, Gözde S. Demirer · 2022 · Frontiers in Genome Editing
  2. CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
    Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, Jingqing Le, Wu-Lin Li, Bingchen Zhang, Chenglei Li, Xun-Huan Song, Ling-Wu Tong, Jingwei Shao · 2023 · Journal of Controlled Release
  3. On the expression of recombinant Cas9 protein in E. coli BL21(DE3) and BL21(DE3) Rosetta strains
    Gabriela Pannunzio Carmignotto, Adriano Rodrigues Azzoni · 2019 · Journal of Biotechnology
  4. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells
    Bingchuan Geng, Kyoung-Han Choi, Shanzhi Wang, Peng Chen, Xiu-Di Pan, Nianguo Dong, Jae‐Kyun Ko, Hua Zhu C · 2020 · Acta Pharmacologica Sinica
  5. Cas9 RNP transfection by vapor nanobubble photoporation for ex vivo cell engineering
    Laurens Raes, Melissa Pille, Aranit Harizaj, Glenn Goetgeluk, Jelter Van Hoeck, Stephan Stremersch, Juan C. Fraire, Toon Brans, Olivier G. de Jong, Roel F. Maas-Bakker et al. · 2021 · Molecular Therapy — Nucleic Acids
  6. Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
    Shuying Feng, Zilong Wang, Aifang Li, Xin Xie, Junjie Liu, Shuxuan Li, Yalan Li, Baiyan Wang, Lina Hu, Lianhe Yang et al. · 2022 · Frontiers in Cell and Developmental Biology
  7. Advances in CRISPR Delivery Methods: Perspectives and Challenges
    Selami Demirci, Khaled Essawi, Paula Germino-Watnick, Xiong Liu, Waleed Hakami, John F. Tisdale · 2022 · The CRISPR Journal
  8. Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy
    Shahin Aghamiri, Sam Talaei, Soheil Roshanzamiri, Farshid Zandsalimi, Elnaz Fazeli, Mansur Aliyu, Omid Kheiry Avarvand, Zahra Ebrahimi, Mahsa Keshavarz‐Fathi, Hossein Ghanbarian · 2020 · Expert Opinion on Drug Delivery
  9. Regulatory aspects, risk assessment, and toxicity associated with RNAi and CRISPR methods
    Shakeel Ahmad, Rahil Shahzad, Shakra Jamil, Javaria Tabassum, Muddassir Ayaz Mahmood Chaudhary, Rana Muhammad Atif, Muhammad Munir Iqbal, Mahmuda Binte Monsur, Yusong Lv, Zhonghua Sheng et al. · 2021 · Elsevier eBooks
  10. Recent electroporation-based systems for intracellular molecule delivery
    Zaizai Dong, Lingqian Chang · 2021 · Nanotechnology and Precision Engineering
  11. DNA, RNA, and Protein Tools for Editing the Genetic Information in Human Cells
    Xiaoyu Chen, Manuel A.F.V. Gonçalves · 2018 · iScience
  12. Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells
    Olga A. Krasheninina, Evgeny K. Apartsin, Elena Fuentes, Aleksandra Szulc, Максим Йонов, Alya G. Venyaminova, Dzmitry Shcharbin, Francisco De la Mata, Maria J Bryszewska, Rafael Gómez · 2019 · Pharmaceutics
  13. Targeted Delivery of mRNA with Polymer–Lipid Nanoparticles for In Vivo Base Editing
    Qimingxing Chen, Yan Chang, Xiaoyan He, Yan Ding, Runyuan Wang, Ran Luo, Jialu Yuan, Jiabei Chen, Guisheng Zhong, Hui Ying Yang et al. · 2025 · ACS Nano
  14. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
    Lulia Koujah, Deepak Shukla, Afsar Raza Naqvi · 2019 · Seminars in Cell and Developmental Biology
  15. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies
    Khaled S. Allemailem, Ahmad Almatroudi, Arshad Husain Rahmani, Faris Alrumaihi, Arwa Essa Alradhi, Amal Al-Subaiyel, Mohammad Algahtani, Rand Mohammad Almousa, Ali Mahzari, Abdulmajeed Abdulghani A. Sindi et al. · 2024 · International Journal of Nanomedicine
  16. Recent advances in the application of CRISPR/Cas-based gene editing technology in Filamentous Fungi
    Xu-Hong Li, Huizhi Lu, Ji-Bao Yao, Chi Zhang, Tian‐Qiong Shi, He Huang · 2025 · Biotechnology Advances
  17. CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
    Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, Young‐Ok Son, Tariq Maqbool · 2025 · Frontiers in Cellular Neuroscience
  18. Synthetic Vehicles for Encapsulation and Delivery of CRISPR/Cas9 Gene Editing Machinery
    Valentina Carboni, Carine Maaliki, Mram Alyami, Shahad K. Alsaiari, Niveen M. Khashab · 2019 · Advanced Therapeutics
  19. The Enhanced Immune Protection in Small Abalone Haliotis diversicolor Against a Secondary Infection With Vibrio harveyi
    Tuo Yao, Jie Lu, Chang-Ming CM Bai, Zhilv Xie, Lingtong Ye · 2021 · Frontiers in Immunology
  20. Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
    Nadia Rouatbi, Tasneem McGlynn, Khuloud T. Al‐Jamal · 2022 · Biomaterials Science
  21. Genetic enhancement: an avenue to combat aging-related diseases
    Yusheng Cai, Zhejun Ji, Si Wang, Weiqi Zhang, Jing Tao Qu, Juan Carlos Izpisúa Belmonte, Guang‐Hui Liu · 2022 · Life Medicine
  22. Molecular insights and omics-based understanding of plant–microbe interactions under drought stress
    Aditya Sharma, Prassan Choudhary, Hillol Chakdar, Pratyoosh Shukla · 2023 · World Journal of Microbiology and Biotechnology
  23. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology
    Jihoon Kim, Bon‐Kyoung Koo, Ki‐Jun Yoon · 2019 · Viruses
  24. CRISPR-Cas systems: Challenges and future prospects
    Nisarg Gohil, Gargi Bhattacharjee, Navya Lavina Lam, Samuel David Perli, Vijai Singh · 2021 · Progress in molecular biology and translational science
  25. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing
    Guillermo Aquino‐Jarquín · 2021 · Molecular Genetics and Metabolism
  26. Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
    Dengyun Nie, Ting Guo, Miao Yue, Wenya Li, Xinyu Zong, Yinxing Zhu, Junxing Huang, Mei Lin · 2022 · Biomolecules
  27. Intracellular Antibody Delivery Mediated by Lipids, Polymers, and Inorganic Nanomaterials for Therapeutic Applications
    Yamin Li, Peixuan Li, Raissa Li, Qiaobing Xu · 2020 · Advanced Therapeutics
  28. Enzymatic Noncovalent Synthesis for Mitochondrial Genetic Engineering of Cancer Cells
    Hongjian He, Xinyi Lin, Difei Wu, Jiaqing Wang, Jiaqi Guo, Douglas R. Green, Hongwei Zhang, Bing Xu · 2020 · Cell Reports Physical Science
  29. Application of Nanoparticle-Based siRNA and CRISPR/Cas9 Delivery Systems in Gene-Targeted Therapy
    Yingkai Tao, Xiaoyang Hou, Fengmei Zuo, Xinxin Li, Yanyu Pang, Guan Jiang · 2019 · Nanomedicine
  30. Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
    Xuefeng Tang, Zhao Wang, Ying Zhang, Wei Mu, Xiaojun Han · 2022 · Chemical Engineering Journal
  31. Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy
    Alba García‐Fernández, Gema Vivo‐Llorca, Mónica Sancho, Alicia Belén García-Jareño, Laura Ramírez‐Jiménez, Eloisa Barber‐Cano, José Ramón Murguía, Mar Orzáez, Félix Sancenón, Ramón Martínez‐Máñez · 2022 · Pharmaceutics
  32. Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems
    Shuting Tang, Xiao-Yin Chen, Xiang-Min Tong, Li-Fen Zhu · 2025 · International Journal of Medical Sciences
  33. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Min Qiu, Zachary Glass, Qiaobing Xu · 2019 · Biomacromolecules
  34. CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
    Ronghua Ding, Jinzhao Long, Mingzhu Yuan, Yuefei Jin, Haiyan Yang, Mengshi Chen, Shuaiyin Chen, Guangcai Duan · 2021 · Frontiers in Cellular and Infection Microbiology
  35. High-throughput methods for genome editing: the more the better
    Yong Huang, Meiqi Shang, Tingting Liu, Kejian Wang · 2022 · PLANT PHYSIOLOGY
  36. Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection
    Huimin Kong, Chenya Zhuo, Ke Yi, Chunxiong Zheng, Rachel L. Mintz, Yeh‐Hsing Lao, Qingguo Zhong, Enguo Ju, Haixia Wang, Dan Shao et al. · 2023 · Nano Today
  37. Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications
    Veronica Guzman Gonzalez, Audrey Grunenberger, Olivier Nicoud, Elodie Czuba, Julien Vollaire, Véronique Josserand, Xavier Le Guével, Nail Desai, Jean‐Luc Coll, Gilles Divita et al. · 2024 · Journal of Controlled Release
  38. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
    Marina A. Tyumentseva, Alexander I. Tyumentsev, В. Г. Акимкин · 2021 · PLoS ONE
  39. Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
    Rahul Bhattacharjee, Ankit Jana, Aditya Nandi, Adrija Sinha, Arkadyuti Bhattacharjee, Sagnik Mitra, Sulagna Kar, Abhijit Dey, Sushil Kumar Singh, Rajender S. Varma et al. · 2022 · Materials & Design
  40. The role of nanoparticles in transforming plant genetic engineering: advancements, challenges and future prospects
    Neelam Rani, Kusum Kumari, Vinita Hooda · 2025 · Functional & Integrative Genomics
  41. Leading approaches in synthetic epigenetics for novel therapeutic strategies
    Kenzo Yamatsugu, Shigehiro A. Kawashima, Motomu Kanai · 2018 · Current Opinion in Chemical Biology
  42. Role of Gene Therapy in Pancreatic Cancer—A Review
    Mizuho Sato‐Dahlman, Keith M. Wirth, Masato Yamamoto · 2018 · Cancers
  43. Applications of CRISPR technologies in transplantation
    Cem Kuscu, Canan Kuscu, Amandeep Bajwa, James D. Eason, Daniel G. Maluf, Valeria R. Mas · 2020 · American Journal of Transplantation
  44. Therapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
    Saint T. Cervera, Carlos Rodriguez‐Martin, Enrique Fernández-Tabanera, Raquel M. Melero-Fernández de Mera, Matías Morin, Sergio Fernández-Peñalver, María Iranzo-Martínez, Jorge Amhih-Cardenas, Laura García‐García, Laura González‐González et al. · 2021 · Cancers
  45. Redesigning small ruminant genomes with CRISPR toolkit: Overview and perspectives
    Peter Kalds, Yawei Gao, Shiwei Zhou, Bei Cai, Xingxu Huang, Xiaolong Wang, Yulin Chen · 2020 · Theriogenology
  46. Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light‐Activated Guide RNA
    Wenyuan Zhou, Wes Brown, Anirban Bardhan, Michael Delaney, Amber S. Ilk, Randy R. Rauen, Shoeb I. Kahn, Michael Tsang, Alexander Deiters · 2020 · Angewandte Chemie
  47. Nanomaterials for gene delivery and editing in plants: Challenges and future perspective
    Mohamed A. Gad, Mingju Li, Farah K. Ahmed, Hassan Almoammar · 2020 · Elsevier eBooks
  48. Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
    Neda Rostami, Mohammad Mahmoudi Gomari, Edris Choupani, Shadi Abkhiz, Mahmood Fadaie, Seyed Sadegh Eslami, Zahra Mahmoudi, Yapei Zhang, Madhu Puri, Fatemeh Nafe Monfared et al. · 2024 · Small Science
  49. Engineering cellulolytic fungi for efficient lignocellulosic biomass hydrolysis: advances in mutagenesis, gene editing, and nanotechnology with CRISPR-Cas innovations
    Harjeet Singh, Komal Janiyani, Ajit Gangawane, Shivani R. Pandya, Srushti Jasani · 2024 · Discover Applied Sciences
  50. Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
    Juliët Schreurs, Claudia Sacchetto, Robin M. W. Colpaert, Libero Vitiello, Alessandra Rampazzo, Martina Calore · 2021 · International Journal of Molecular Sciences
  51. In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome–DNA Complexes
    Diana A. Sousa, Ricardo Gaspar, Celso J. O. Ferreira, Fátima Baltazar, Lígia R. Rodrigues, Bruno F. B. Silva · 2022 · Pharmaceutics
  52. CRISPR/Cas9 in the era of nanomedicine and synthetic biology
    Tiziana Julia Nadjeschda Schmidt, Barbara Berarducci, Soultana Konstantinidou, Vittoria Raffa · 2022 · Drug Discovery Today
  53. Lipid and polymer mediated CRISPR/Cas9 gene editing
    Yan Gong, Siyu Tian, Xuan Yang, Shubiao Zhang · 2020 · Journal of Materials Chemistry B
  54. Active Delivery of CRISPR System Using Targetable or Controllable Nanocarriers
    Yan Lyu, Cheng Yang, Xiaomei Lyu, Kanyi Pu · 2021 · Small
  55. CRISPR for accelerating genetic gains in under-utilized crops of the drylands: progress and prospects
    Sharma, Kiran K., Palakolanu, Sudhakar Reddy, Bhattacharya, Joorie, Shankhapal, Aishwarya R., Bhatnagar-Mathur, Pooja · 2022 · Frontiers in Genetics
  56. Interactions Between Immunomodulatory Biomaterials and Immune Microenvironment: Cues for Immunomodulation Strategies in Tissue Repair
    Yi Chen, Weiyan Sun, Hai Tang, Yingze Li, Chen Li, Long Wang, Jiafei Chen, Weikang Lin, Shenghui Li, Ziwen Fan et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  57. Past, present, and future of genetic strategies to control tolerance to the main fungal and oomycete pathogens of grapevine
    Carlotta Pirrello, Gabriele Magon, Fabio Palumbo, Silvia Farinati, Margherita Lucchin, Gianni Barcaccia, Alessandro Vannozzi · 2022 · Journal of Experimental Botany
  58. CRISPR, CAR-T, and NK: Current applications and future perspectives
    Mohadeseh Khoshandam, Hossein Soltaninejad, Amir Ali Hamidieh, Saman Hosseinkhani · 2023 · Genes & Diseases
  59. Gene editing for inflammatory disorders
    David T. Ewart, Erik J Peterson, Clifford J. Steer · 2018 · Annals of the Rheumatic Diseases
  60. SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research
    Anthony Lima, Danilo Maddalo · 2021 · Frontiers in Oncology
  61. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
    Weiqi Cai, Tianli Luo, Lanqun Mao, Ming Wang · 2020 · Angewandte Chemie
  62. In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia
    Jeong Hyeon Lee, Jeong Pil Han · 2024 · Molecular Diagnosis & Therapy
  63. THE JOURNEY OF CRISPR-CAS9 FROM BACTERIAL DEFENSE MECHANISM TO A GENE EDITING TOOL IN BOTH ANIMALS AND PLANTS
    T Tahir, Qurban Ali, MS Rashid, Arif Malik · 2020 · Biological and Clinical Sciences Research Journal
  64. Multivalent Peptide-Functionalized Bioreducible Polymers for Cellular Delivery of Various RNAs
    Dong‐Chu Yang, Alexander C. Eldredge, James C. Hickey, Hurik Muradyan, Zhibin Guan · 2020 · Biomacromolecules
  65. CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip
    Noshad Peyravian, Maziar Malekzadeh Kebria, Jafar Kiani, Peiman Brouki Milan, Masoud Mozafari · 2021 · Materials
  66. Emerging lipid–polymer hybrid nanoparticles for genome editing
    Mariana d'Almeida Gameiro, João Filipe Mano, Vítor M. Gaspar · 2024 · Polymer Chemistry
  67. Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Complex
    Ashu Srivastav, Kritika Gupta, Debojyoti Chakraborty, Prajakta P. Dandekar, Ratnesh D. Jain · 2020 · Journal of Pharmaceutical Innovation
  68. Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer
    Jia‐Lun Duan, Chun‐Jie Bao, Ying Xie, Haitao Guo, Yixuan Liu, Jianwei Li, Rui Liu, Peishan Li, Jing Bai, Yan Yan et al. · 2021 · Bioactive Materials
  69. Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells
    Waleed M. Kholosy, Marieke Visscher, Kim Ogink, Helen Buttstedt, Kelli Griffin, Axel Beier, Jan P. Gerlach, Jan J. Molenaar, Niels Geijsen, Marco de Boer et al. · 2021 · Journal of Biotechnology
  70. CRISPR/Cas gene editing in the human germline
    Bieke Bekaert, Annekatrien Boel, Gwenny Cosemans, Lisa De Witte, Björn Menten, Björn Heindryckx · 2022 · Seminars in Cell and Developmental Biology
  71. Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
    Qianqian Zhou, Yanhua Chen, Ruolei Wang, Fengjing Jia, Feng He, Fuwen Yuan · 2022 · Genes & Diseases
  72. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
    Bixi Sun, Hening Chen, Xiaoshu Gao · 2021 · Journal of Controlled Release
  73. Understanding the Potential of Genome Editing in Parkinson’s Disease
    David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch · 2021 · International Journal of Molecular Sciences
  74. HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy
    Atefeh Zamani Kermanshahi, Fatemeh Ebrahimi, Ahmad Taherpoor, Narges Eslami, Hossein Bannazadeh Baghi · 2025 · Virology Journal
  75. Nanoparticles-assisted phytoremediation: Advances and applications
    Omena Bernard Ojuederie, Adenike Eunice Amoo, Shesan John Owonubi, Ayansina Segun Ayangbenro · 2021 · Elsevier eBooks
  76. The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
    Huanhuan Qiao, Jieting Wu, Xiaodong Zhang, Jian Luo, Hao Wang, Dong Ming · 2021 · Frontiers in Chemistry
  77. The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells
    Marina Mohr, Nkerorema Djodji Damas, Johanne Gudmand‐Hoeyer, Katrine Zeeberg, Dominika Jędrzejczyk, Arsenios Vlassis, Martí Morera-Gómez, Sara Pereira, Urška Puš, Anna Oliver-Almirall et al. · 2023 · ACS Synthetic Biology
  78. Poly(β-amino ester) Nanoparticles Modified with a Rabies-Virus-Derived Peptide for the Delivery of ASCL1 across a 3D In Vitro Model of the Blood–Brain Barrier
    Tina M. Rodgers, Nicolás Muzzio, Andrea Valero, Ikram Ahmad, Tanja Ursula Lüdtke, Sergio Enrique Moya, Gabriela Romero · 2023 · ACS Applied Nano Materials
  79. Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
    Giulio Preta · 2023 · Cells
  80. Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases?
    Ina Guri, Yara Alrokh, Young‐Ah Kim, Ruhina Maeshima, Carina Graham, Stephen L. Hart, John Alexander McGrath, J. Jackow · 2023 · British Journal of Dermatology
  81. CRISPR delivery systems for organ-specific targeting: Advances and challenges
    Jun Du, Qinjie Wu, Chao Liu, Ning Wang, Changyang Gong · 2025 · Precision medicine and engineering.
  82. Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
    Eun-Jeong Won, Hyeji Park, Tae‐Jong Yoon, Young‐Seok Cho · 2022 · Pharmaceutics
  83. Fshb Knockout Mouse Model, Two Decades Later and Into the Future
    T. Rajendra Kumar · 2018 · Endocrinology
  84. Combinatorial Library of Light-Cleavable Lipidoid Nanoparticles for Intracellular Drug Delivery
    Yamin Li, Anirban Chakraborty, Jinjin Chen, Qiaobing Xu · 2019 · ACS Biomaterials Science & Engineering
  85. A comprehensive review of advanced strategies to combat antimicrobial resistance
    Bikramaditya Behera, R. P. Singh, Komal Sharma, Ansh Rai, Shreya Singh, Biji Balan · 2025 · Archives of Microbiology
  86. Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes
    Zhang Chuan-ping, Hou-Yuan Qiu, Caixiang Zhang, Yuming Zhang, Yizhou Zhang, Hao Yin, Ke‐Qin Zhang, Ying Zhang · 2023 · Journal of Molecular Cell Biology
  87. CRISPR/Cas9-Mediated Genome Editing for Abiotic Stress Tolerance in Crops: Current Advances and Future Prospects
    Venkatesan Ajithkumar, K. B. Soni, Swapna Alex, T. Swathi Anuradha, Rehna Augustine, R. V. Manju · 2025 · Plant Molecular Biology Reporter
  88. A concise review on development of probiotics from Lactobacillus using CRISPR-Cas technology of gene editing
    Siddharth Vaid, Vinay Kumar Pandey, RAHUL KUNWAR SINGH, Aamir Hussain Dar, Rafeeya Shams, Ketan Singh Thakur · 2022 · Food Chemistry Advances
  89. Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
    Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, Allie Ivy, Daniel A. Maxenberger, Landon A. Burcham, Christopher E. Nelson · 2023 · Biophysics Reviews
  90. Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo
    Yunping Hu, Baisong Lu, Zhiyong Deng, Fei Xing, Wesley Hsu · 2023 · Discover Oncology
  91. Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9
    Shiva Shirani-Bidabadi, Mina Mirian, Jaleh Varshosaz, Nazita Tavazohi, M. Hamid, Laleh Shariati · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
  92. Delivery strategies of RNA therapeutics to leukocytes
    Dana Tarab‐Ravski, Lior Stotsky‐Oterin, Dan Peer · 2022 · Journal of Controlled Release
  93. Responsive MXene nanovehicles deliver CRISPR/Cas12a for boolean logic-controlled gene editing
    Song Wang, Zhenhua Zhang, Rui Tang, Fang He, Yan Huang, Zhou Nie, Chunyang Lei · 2022 · Science China Chemistry
  94. A peptide delivery system sneaks CRISPR into cells
    Xingang Guan, Zhimin Luo, Wujin Sun · 2018 · Journal of Biological Chemistry
  95. The application of gene silencing in proteomics: from laboratory to clinic
    Maura Brioschi, Cristina Banfi · 2018 · Expert Review of Proteomics
  96. Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy
    Hyunsu Shin, Jaeyun Kim · 2022 · Chemical Communications
  97. Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
    Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler · 2024 · International Journal of Molecular Sciences
  98. Efficient Intracellular Delivery of Crispr-Cas9 Ribonucleoproteins Using Dendrimer Nanoparticles for Robust Genomic Editing
    Wathsala Liyanage, Gokul R. Kannan, Sujatha Kannan, Rangaramanujam M. Kannan · 2024 · Nano Today
  99. Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology
    Ocean Khajuria, Neha Sharma · 2021 · Advances in Cancer Biology - Metastasis
  100. Modulating CRISPR gene drive activity through nucleocytoplasmic localization of Cas9 in S. cerevisiae
    Megan E. Goeckel, Erianna M. Basgall, Isabel C. Lewis, Samantha C. Goetting, Yao Yan, Megan Halloran, Gregory C. Finnigan · 2019 · Fungal Biology and Biotechnology